14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Jul 25, 2014 Buy 18 239 594 Cannabics Inc. COMMON STOCK
Jun 23, 2014 Buy 14 525 000 Cannabics Inc. Common Stock
May 08, 2014 Buy 20 500 000 Cannabics Inc. Common Stock
May 08, 2014 Sell 20 500 000 Mills Thomas E common stock
Apr 25, 2014 Buy 20 500 000 Mills Thomas E common stock
Oct 28, 2013 Buy 20 000 000 Mills Thomas E COMMON STOCK
Oct 28, 2013 Buy 20 000 000 Mills Thomas E COMMON STOCK
Jun 28, 2013 Sell 20 000 000 Mills Thomas E common stock
Jun 24, 2013 Buy 20 000 000 Mills Thomas E common stock
Nov 08, 2011 Sell 31 000 000 North American Mining Corp common stock
May 31, 2011 Buy 0 North American Mining Corp common stock
Sep 25, 2007 Sell 2 000 000 Hilford Lou common
Sep 25, 2007 Buy 2 000 000 Mills Thomas E common
Apr 13, 2006 Buy 0 Hilford Lou common stock
Apr 12, 2006 Buy 0 Mills Thomas E common stock
INSIDER POWER
0
Last 15 transactions
Buy: 135 764 594 | Sell: 73 500 000 (Shares)

Based on the 15 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 135 764 594 and sold 73 500 000 CNBX shares in the last 15 trades.

Click to get the best stock tips daily for free!

About Cannabics Pharma

Cannabics Pharma CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal p... CNBX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT